| OARSI guidelines for the non-surgical management of knee osteoarthritis TE McAlindon, RR Bannuru, MC Sullivan, NK Arden, F Berenbaum, ... Osteoarthritis and cartilage 22 (3), 363-388, 2014 | 2532 | 2014 |
| Osteoarthritis: an update with relevance for clinical practice JWJ Bijlsma, F Berenbaum, FPJG Lafeber The Lancet 377 (9783), 2115-2126, 2011 | 1793 | 2011 |
| Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) F Berenbaum Osteoarthritis and cartilage 21 (1), 16-21, 2013 | 1124 | 2013 |
| The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis J Sellam, F Berenbaum Nature Reviews Rheumatology 6 (11), 625, 2010 | 956 | 2010 |
| Primary culture and phenotyping of murine chondrocytes M Gosset, F Berenbaum, S Thirion, C Jacques Nature protocols 3 (8), 1253, 2008 | 413 | 2008 |
| Obesity and osteoarthritis: more complex than predicted! P Pottie, N Presle, B Terlain, P Netter, D Mainard, F Berenbaum Annals of the rheumatic diseases 65 (11), 1403-1405, 2006 | 403 | 2006 |
| The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide MB Goldring, F Berenbaum Clinical Orthopaedics and Related Research® 427, S37-S46, 2004 | 334 | 2004 |
| Stigmasterol: a phytosterol with potential anti-osteoarthritic properties O Gabay, C Sanchez, C Salvat, F Chevy, M Breton, G Nourissat, C Wolf, ... Osteoarthritis and cartilage 18 (1), 106-116, 2010 | 296 | 2010 |
| Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study G Schett, A Kleyer, C Perricone, E Sahinbegovic, A Iagnocco, J Zwerina, ... Diabetes care 36 (2), 403-409, 2013 | 274 | 2013 |
| Anti–tumor necrosis factor α therapy in fifteen patients with aa amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy JE Gottenberg, F Merle‐Vincent, F Bentaberry, Y Allanore, F Berenbaum, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 267 | 2003 |
| The role of IL‐1 and IL‐1Ra in joint inflammation and cartilage degradation C Jacques, M Gosset, F Berenbaum, C Gabay Vitamins & Hormones 74, 371-403, 2006 | 245 | 2006 |
| Osteoarthritis, inflammation and obesity F Berenbaum, F Eymard, X Houard Current opinion in rheumatology 25 (1), 114-118, 2013 | 241 | 2013 |
| Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype F Berenbaum Postgraduate medical journal 88 (1038), 240-242, 2012 | 241 | 2012 |
| Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis X Houard, MB Goldring, F Berenbaum Current rheumatology reports 15 (11), 375, 2013 | 236 | 2013 |
| Is osteoarthritis a metabolic disease? J Sellam, F Berenbaum Joint bone spine 80 (6), 568-573, 2013 | 230 | 2013 |
| Tendon injury: from biology to tendon repair G Nourissat, F Berenbaum, D Duprez Nature Reviews Rheumatology 11 (4), 223, 2015 | 198 | 2015 |
| Crucial role of visfatin/pre–B cell colony‐enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: Possible influence on osteoarthritis M Gosset, F Berenbaum, C Salvat, A Sautet, A Pigenet, K Tahiri, ... Arthritis & Rheumatism 58 (5), 1399-1409, 2008 | 197 | 2008 |
| The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients M Dougados, MA d’Agostino, J Benessiano, F Berenbaum, M Breban, ... Joint Bone Spine 78 (6), 598-603, 2011 | 196 | 2011 |
| The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients B Combe, J Benessiano, F Berenbaum, A Cantagrel, JP Daurès, ... Joint bone spine 74 (5), 440-445, 2007 | 191 | 2007 |
| Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib MC Hochberg, J Martel-Pelletier, J Monfort, I Möller, JR Castillo, N Arden, ... Annals of the rheumatic diseases 75 (1), 37-44, 2016 | 190 | 2016 |
